Trial Site Detail
Drug: |
Imatinib |
|||
|---|---|---|---|---|
Trial: |
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Active, not recruiting |
|||
Asan Medical center |
Principal Investigator: |
Yoon-Koo Kang, MD, PhD |
|---|---|
Contact: |
+82-2-3010-3230 ykkang@amc.seoul.kr |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Asan Medical center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.